|
|
![]() | ![]() | ![]() | ![]() |
These excerpts taken from the WBMD 10-K filed Feb 27, 2009. Anti-Kickback
Laws
There are federal and state laws that govern patient referrals,
physician financial relationships and inducements to healthcare
providers and patients. The federal healthcare programs
anti-kickback law prohibits any person or entity from offering,
paying, soliciting or receiving anything of value, directly or
indirectly, for the referral of patients covered by Medicare,
Medicaid and other federal healthcare programs or the leasing,
Table of Contents
purchasing, ordering or arranging for or recommending the lease,
purchase or order of any item, good, facility or service covered
by these programs. Many states also have similar anti-kickback
laws that are not necessarily limited to items or services for
which payment is made by a federal healthcare program. These
laws are applicable to manufacturers and distributors and,
therefore, may restrict how we and some of our customers market
products to healthcare providers, including
e-details.
Also, in 2002, the Office of the Inspector General (or OIG) of
the United States Department of Health and Human Services (or
HHS), the federal government agency responsible for interpreting
the federal anti-kickback law, issued an advisory opinion that
concluded that the sale of advertising and sponsorships to
healthcare providers and vendors by Web-based information
services implicates the federal anti-kickback law. However, the
advisory opinion suggests that enforcement action will not
result if the fees paid represent fair market value for the
advertising/sponsorship arrangements, the fees do not vary based
on the volume or value of business generated by the advertising
and the advertising/sponsorship relationships are clearly
identified as such to users. We carefully review our practices
with regulatory experts in an effort to ensure that we comply
with all applicable laws. However, the laws in this area are
both broad and vague, and it is often difficult or impossible to
determine precisely how the laws will be applied, particularly
to new services. Penalties for violating the federal
anti-kickback law include imprisonment, fines and exclusion from
participating, directly or indirectly, in Medicare, Medicaid and
other federal healthcare programs. Any determination by a state
or federal regulatory agency that any of our practices violate
any of these laws could subject us to civil or criminal
penalties and require us to change or terminate some portions of
our business and could have an adverse effect on our business.
Even an unsuccessful challenge by regulatory authorities of our
practices could cause us adverse publicity and be costly for us
to respond to.
Anti-Kickback Laws There are federal and state laws that govern patient referrals, physician financial relationships and inducements to healthcare providers and patients. The federal healthcare programs anti-kickback law prohibits any person or entity from offering, paying, soliciting or receiving anything of value, directly or indirectly, for the referral of patients covered by Medicare, Medicaid and other federal healthcare programs or the leasing,
Table of Contentspurchasing, ordering or arranging for or recommending the lease, purchase or order of any item, good, facility or service covered by these programs. Many states also have similar anti-kickback laws that are not necessarily limited to items or services for which payment is made by a federal healthcare program. These laws are applicable to manufacturers and distributors and, therefore, may restrict how we and some of our customers market products to healthcare providers, including e-details. Also, in 2002, the Office of the Inspector General (or OIG) of the United States Department of Health and Human Services (or HHS), the federal government agency responsible for interpreting the federal anti-kickback law, issued an advisory opinion that concluded that the sale of advertising and sponsorships to healthcare providers and vendors by Web-based information services implicates the federal anti-kickback law. However, the advisory opinion suggests that enforcement action will not result if the fees paid represent fair market value for the advertising/sponsorship arrangements, the fees do not vary based on the volume or value of business generated by the advertising and the advertising/sponsorship relationships are clearly identified as such to users. We carefully review our practices with regulatory experts in an effort to ensure that we comply with all applicable laws. However, the laws in this area are both broad and vague, and it is often difficult or impossible to determine precisely how the laws will be applied, particularly to new services. Penalties for violating the federal anti-kickback law include imprisonment, fines and exclusion from participating, directly or indirectly, in Medicare, Medicaid and other federal healthcare programs. Any determination by a state or federal regulatory agency that any of our practices violate any of these laws could subject us to civil or criminal penalties and require us to change or terminate some portions of our business and could have an adverse effect on our business. Even an unsuccessful challenge by regulatory authorities of our practices could cause us adverse publicity and be costly for us to respond to. These excerpts taken from the WBMD 10-K filed Feb 29, 2008. Anti-Kickback
Laws
There are federal and state laws that govern patient referrals,
physician financial relationships and inducements to healthcare
providers and patients. The federal healthcare programs
anti-kickback law prohibits any person or entity from offering,
paying, soliciting or receiving anything of value, directly or
indirectly, for the referral of patients covered by Medicare,
Medicaid and other federal healthcare programs or the leasing,
purchasing, ordering or arranging for or recommending the lease,
purchase or order of any item, good, facility or service covered
by these programs. Many states also have similar anti-kickback
laws that are not necessarily limited to items or services for
which payment is made by a federal healthcare program. These
laws are applicable to manufacturers and distributors and,
therefore, may restrict how we and some of our customers market
products to healthcare providers, including
e-details.
Also, in 2002, the Office of the Inspector General (or OIG) of
the United States Department of Health and Human Services (or
HHS), the federal government agency responsible for interpreting
the federal anti-kickback law, issued an advisory opinion that
concluded that the sale of advertising and sponsorships to
healthcare providers and vendors by Web-based information
services implicates the federal anti-kickback law. However, the
advisory opinion suggests that enforcement action will not
result if the fees paid represent fair market value for the
advertising/sponsorship arrangements, the fees do not vary based
on the volume or value of business generated by the advertising
and the advertising/sponsorship relationships are clearly
identified as such to users. We carefully review our practices
with regulatory experts in an effort to ensure that we comply
with all applicable laws. However, the laws in this area are
both broad and vague, and it is often difficult or impossible to
determine precisely how the laws will be applied, particularly
to new services. Penalties for violating the federal
anti-kickback law include imprisonment, fines and exclusion from
participating, directly or indirectly, in Medicare, Medicaid and
other federal healthcare programs. Any determination by a state
or federal regulatory agency that any of our practices violate
any of these laws could subject us to civil or criminal
penalties and require us to change or terminate some portions of
our business and could have an adverse effect on our business.
Even an unsuccessful challenge by regulatory authorities of our
practices could cause us adverse publicity and be costly for us
to respond to.
Anti-Kickback Laws There are federal and state laws that govern patient referrals, physician financial relationships and inducements to healthcare providers and patients. The federal healthcare programs anti-kickback law prohibits any person or entity from offering, paying, soliciting or receiving anything of value, directly or indirectly, for the referral of patients covered by Medicare, Medicaid and other federal healthcare programs or the leasing, purchasing, ordering or arranging for or recommending the lease, purchase or order of any item, good, facility or service covered by these programs. Many states also have similar anti-kickback laws that are not necessarily limited to items or services for which payment is made by a federal healthcare program. These laws are applicable to manufacturers and distributors and, therefore, may restrict how we and some of our customers market products to healthcare providers, including e-details. Also, in 2002, the Office of the Inspector General (or OIG) of the United States Department of Health and Human Services (or HHS), the federal government agency responsible for interpreting the federal anti-kickback law, issued an advisory opinion that concluded that the sale of advertising and sponsorships to healthcare providers and vendors by Web-based information services implicates the federal anti-kickback law. However, the advisory opinion suggests that enforcement action will not result if the fees paid represent fair market value for the advertising/sponsorship arrangements, the fees do not vary based on the volume or value of business generated by the advertising and the advertising/sponsorship relationships are clearly identified as such to users. We carefully review our practices with regulatory experts in an effort to ensure that we comply with all applicable laws. However, the laws in this area are both broad and vague, and it is often difficult or impossible to determine precisely how the laws will be applied, particularly to new services. Penalties for violating the federal anti-kickback law include imprisonment, fines and exclusion from participating, directly or indirectly, in Medicare, Medicaid and other federal healthcare programs. Any determination by a state or federal regulatory agency that any of our practices violate any of these laws could subject us to civil or criminal penalties and require us to change or terminate some portions of our business and could have an adverse effect on our business. Even an unsuccessful challenge by regulatory authorities of our practices could cause us adverse publicity and be costly for us to respond to. This excerpt taken from the WBMD 10-K filed Mar 2, 2007. Anti-Kickback
Laws
There are federal and state laws that govern patient referrals,
physician financial relationships and inducements to healthcare
providers and patients. The federal healthcare programs
anti-kickback law prohibits any person or entity from offering,
paying, soliciting or receiving anything of value, directly or
indirectly, for the referral of patients covered by Medicare,
Medicaid and other federal healthcare programs or the leasing,
purchasing, ordering or arranging for or recommending the lease,
purchase or order of any item, good, facility
Table of Contents
or service covered by these programs. Many states also have
similar anti-kickback laws that are not necessarily limited to
items or services for which payment is made by a federal
healthcare program. These laws are applicable to manufacturers
and distributors and, therefore, may restrict how we and some of
our customers market products to healthcare providers, including
e-details. Also, in 2002, the Office of the Inspector General
(or OIG) of the United States Department of Health and Human
Services (or HHS), the federal government agency responsible for
interpreting the federal anti-kickback law, issued an advisory
opinion that concluded that the sale of advertising and
sponsorships to healthcare providers and vendors by Web-based
information services implicates the federal anti-kickback law.
However, the advisory opinion suggests that enforcement action
will not result if the fees paid represent fair market value for
the advertising/sponsorship arrangements, the fees do not vary
based on the volume or value of business generated by the
advertising and the advertising/sponsorship relationships are
clearly identified as such to users. We carefully review our
practices with regulatory experts in an effort to ensure that we
comply with all applicable laws. However, the laws in this area
are both broad and vague, and it is often difficult or
impossible to determine precisely how the laws will be applied,
particularly to new services. Penalties for violating the
federal anti-kickback law include imprisonment, fines and
exclusion from participating, directly or indirectly, in
Medicare, Medicaid and other federal healthcare programs. Any
determination by a state or federal regulatory agency that any
of our practices violate any of these laws could subject us to
civil or criminal penalties and require us to change or
terminate some portions of our business and could have an
adverse effect on our business. Even an unsuccessful challenge
by regulatory authorities of our practices could cause us
adverse publicity and be costly for us to respond to.
This excerpt taken from the WBMD 10-K filed Mar 16, 2006. Anti-Kickback
Laws
There are federal and state laws that govern patient referrals,
physician financial relationships and inducements to healthcare
providers and patients. The federal healthcare programs
anti-kickback law prohibits
Table of Contents
any person or entity from offering, paying, soliciting or
receiving anything of value, directly or indirectly, for the
referral of patients covered by Medicare, Medicaid and other
federal healthcare programs or the leasing, purchasing, ordering
or arranging for or recommending the lease, purchase or order of
any item, good, facility or service covered by these programs.
Many states also have similar anti-kickback laws that are not
necessarily limited to items or services for which payment is
made by a federal healthcare program. These laws are applicable
to manufacturers and distributors and, therefore, may restrict
how we and some of our customers market products to healthcare
providers. Also, in 2002, the Office of the Inspector General
(or OIG) of the United States Department of Health and Human
Services (or HHS), the federal government agency responsible for
interpreting the federal anti-kickback law, issued an advisory
opinion that concluded that the sale of advertising and
sponsorships to healthcare providers and vendors by Web-based
information services implicates the federal anti-kickback law.
However, the advisory opinion suggests that enforcement action
will not result if the fees paid represent fair market value for
the advertising/sponsorship arrangements, the fees do not vary
based on the volume or value of business generated by the
advertising and the advertising/sponsorship relationships are
clearly identified as such to users. We carefully review our
practices with regulatory experts in an effort to ensure that we
comply with all applicable laws. However, the laws in this area
are both broad and vague, and it is often difficult or
impossible to determine precisely how the laws will be applied,
particularly to new services. Penalties for violating the
federal anti-kickback law include imprisonment, fines and
exclusion from participating, directly or indirectly, in
Medicare, Medicaid and other federal healthcare programs. Any
determination by a state or federal regulatory agency that any
of our practices violate any of these laws could subject us to
civil or criminal penalties and require us to change or
terminate some portions of our business and could have an
adverse effect on our business. Even an unsuccessful challenge
by regulatory authorities of our practices could cause us
adverse publicity and be costly for us to respond to.
| EXCERPTS ON THIS PAGE:
|
| |||||||